Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie; Lars Køber; Peter Skov Olsen; Charlotte Andersson; Gunnar Gislason; Jan Skov Jensen; Christian Torp-Pedersen

doi:10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

Charlotte Mérie, Lars Køber, Peter Skov Olsen, Charlotte Andersson, Gunnar Gislason, Jan Skov Jensen, Christian Torp-Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

202 Citationer (Scopus)

Abstract

The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

Originalsprog	Engelsk
Tidsskrift	J A M A: The Journal of the American Medical Association
Vol/bind	308
Udgave nummer	20
Sider (fra-til)	2118-25
Antal sider	8
ISSN	0098-7484
DOI	https://doi.org/10.1001/jama.2012.54506
Status	Udgivet - 2012

Adgang til dokumentet

10.1001/jama.2012.54506

Citationsformater

Mérie, C., Køber, L., Skov Olsen, P., Andersson, C., Gislason, G., Skov Jensen, J., & Torp-Pedersen, C. (2012). Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. J A M A: The Journal of the American Medical Association, 308(20), 2118-25. https://doi.org/10.1001/jama.2012.54506

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. / Mérie, Charlotte; Køber, Lars; Skov Olsen, Peter et al.
I: J A M A: The Journal of the American Medical Association, Bind 308, Nr. 20, 2012, s. 2118-25.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Mérie, C, Køber, L, Skov Olsen, P, Andersson, C, Gislason, G, Skov Jensen, J & Torp-Pedersen, C 2012, 'Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding', J A M A: The Journal of the American Medical Association, bind 308, nr. 20, s. 2118-25. https://doi.org/10.1001/jama.2012.54506

@article{5bd5a6836e7b4a71b70ea97f6ba71fe5,

title = "Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding",

abstract = "The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.",

author = "Charlotte M{\'e}rie and Lars K{\o}ber and {Skov Olsen}, Peter and Charlotte Andersson and Gunnar Gislason and {Skov Jensen}, Jan and Christian Torp-Pedersen",

year = "2012",

doi = "10.1001/jama.2012.54506",

language = "English",

volume = "308",

pages = "2118--25",

journal = "J A M A: The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "20",

}

TY - JOUR

T1 - Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding

AU - Mérie, Charlotte

AU - Køber, Lars

AU - Skov Olsen, Peter

AU - Andersson, Charlotte

AU - Gislason, Gunnar

AU - Skov Jensen, Jan

AU - Torp-Pedersen, Christian

PY - 2012

Y1 - 2012

N2 - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

AB - The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.

U2 - 10.1001/jama.2012.54506

DO - 10.1001/jama.2012.54506

M3 - Journal article

C2 - 23188028

SN - 0098-7484

VL - 308

SP - 2118

EP - 2125

JO - J A M A: The Journal of the American Medical Association

JF - J A M A: The Journal of the American Medical Association

IS - 20

ER -